We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Closure System Permanently Seals Varicose Veins

By HospiMedica International staff writers
Posted on 01 Mar 2015
Print article
Image: The VenaSeal Closure System (Photo courtesy of Sapheon).
Image: The VenaSeal Closure System (Photo courtesy of Sapheon).
A novel embolic system uses an adhesive agent that polymerizes inside superficial varicose veins of the legs, sealing them shut.

The VenaSeal Closure System is composed of a specially formulated adhesive (n-butyl-2-cyanoacrylate) and a delivery system that includes a catheter, guidewire, dispenser gun, dispenser tips, and syringes. The VenaSeal Closure System does not require tumescent anesthesia to be injected peripherally into the leg, and because there are no pre-procedures drugs involved, patients can usually return to their normal activities right after the treatment, with just a Band-Aid in place.

For example, to seal the great saphenous vein (GSV), the catheter is first guided via ultrasound (US) towards the saphenofemoral junction (SFJ); once properly placed near the SFJ, the adhesive is injected into the lumen, sealing the vein. The procedure is then repeated every three cm along the GSV. Once closed, blood is immediately rerouted through other healthy veins in the leg. The VenaSeal Closure system is a product of Sapheon (Morrisville, NC, USA), a part of Covidien (Dublin, Ireland), and has been approved by the US Food and Drug Administration (FDA).

“Cyanoacrylate embolization is an effective and durable solution to the problem of incompetent great saphenous veins; long-term effectiveness is high,” said Prof. Thomas Proebstle, MD, of Mainz University (Germany), who led the European multicenter clinical study of the system. “The elimination of the need for perivenous tumescent anesthesia and post-interventional compression stockings, along with the associated side effects, results in significantly improved treatment.”

“This new system is the first to permanently treat varicose veins by sealing them with an adhesive, thereby giving patients another treatment option for this common condition,” said William Maisel, MD, MPH, acting director of the office of device evaluation in the FDA’s Center for Devices and Radiological Health (CDRH). “Because the VenaSeal system does not incorporate heat application or cutting, the in-office procedure can allow patients to quickly return to their normal activities, with less bruising.”

Varicose veins (also known as venous reflux disease) occur when valves inside the veins break and blood is unable to circulate properly. This is a common condition that affects both men (25%) and women (40%). Varicose veins can occur anywhere from the groin to the ankle.

Related Links:

Sapheon
Covidien


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.